Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity

Authors

Raymond S Douglas, Sinai Medical Center
Steven Couch, Washington University School of Medicine in St. Louis
Sara T Wester, University of Miami
Brian T Fowler, University of Tennessee Health Science Center
Catherine Y Liu, University of California - San Diego
Prem S Subramanian, University of Colorado
Rosa Tang, Eye Wellness Center
Quang T Nguyen, Touro University
Robi N Maamari, Washington University School of Medicine in St. Louis
Shoaib Ugradar, Sinai Medical Center
Kate Hsu, Horizon Therapeutics
Michael Karon, Horizon Therapeutics
Marius N Stan, Mayo Clinic

Journal

The Journal of clinical endocrinology & metabolism

Publication Date

12-21-2023

Volume

109

Issue

1

First Page

25

Last Page

35

Document Type

Open Access Publication

DOI

10.1210/clinem/dgad637

Rights and Permissions

Raymond S Douglas, Steven Couch, Sara T Wester, Brian T Fowler, Catherine Y Liu, Prem S Subramanian, Rosa Tang, Quang T Nguyen, Robi N Maamari, Shoaib Ugradar, Kate Hsu, Michael Karon, Marius N Stan, Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages 25–35, https://doi.org/10.1210/clinem/dgad637. https://academic.oup.com/jcem/article/109/1/25/7334391?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Douglas, Raymond S; Couch, Steven; Wester, Sara T; Fowler, Brian T; Liu, Catherine Y; Subramanian, Prem S; Tang, Rosa; Nguyen, Quang T; Maamari, Robi N; Ugradar, Shoaib; Hsu, Kate; Karon, Michael; and Stan, Marius N, "Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity." The Journal of clinical endocrinology & metabolism. 109, 1. 25 - 35. (2023).
https://digitalcommons.wustl.edu/oa_4/4696

Department

ICTS (Institute of Clinical and Translational Sciences)